Your browser doesn't support javascript.
loading
Discovery of an Azabicyclo[2.1.1]hexane Piperazinium Salt and Its Application in Medicinal Chemistry via a Rearrangement.
He, Chi; Ba, Xiaochu; Shunatona, Hunter P; Edwards, Jacob T; Li, Yi-Xin; Keller, Taylor M; Sommer, Roger D; Zapf, Christoph W; Mortensen, Deborah S.
Afiliação
  • He C; Small Molecule Drug Discovery, Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States.
  • Ba X; Small Molecule Drug Discovery, Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States.
  • Shunatona HP; Small Molecule Drug Discovery, Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States.
  • Edwards JT; Small Molecule Drug Discovery, Bristol Myers Squibb, 700 Bay Road, Redwood City, California 94063, United States.
  • Li YX; Small Molecule Drug Discovery, Bristol Myers Squibb, 700 Bay Road, Redwood City, California 94063, United States.
  • Keller TM; Chemical Process Development, Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08901, United States.
  • Sommer RD; Chemical Process Development, Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08901, United States.
  • Zapf CW; Small Molecule Drug Discovery, Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States.
  • Mortensen DS; Small Molecule Drug Discovery, Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States.
Org Lett ; 26(25): 5318-5322, 2024 Jun 28.
Article em En | MEDLINE | ID: mdl-38888237
ABSTRACT
Herein we report the discovery of an azabicyclo[2.1.1]hexane piperazinium methanesulfonate salt from an unexpected rearrangement reaction in the preparation of ligand-directed degraders (LDDs). This bench-stable compound was found to be a versatile electrophile in a ring-opening reaction with various types of nucleophiles. Its utility as a versatile medicinal chemistry building block is further demonstrated in the synthesis of an LDD compound targeting degradation of the androgen receptor.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Compostos Azabicíclicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Compostos Azabicíclicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article